Skip to main content

Table 2 Treatment outcome

From: Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania

Outcome

PCR uncorrected

PCR corrected

Under-fives (n = 51)*

  

Early Treatment Failure (ETF)

0 (0%)

0 (0%)

Late Clinical Failure (LCF)

3 (5.6%)***

0 (0%)

Late Parasitological Failure (LPF)

8 (15.7%)***

0 (0%)

Adequate Clinical and Parasitological Response (ACPR)

40 (78.4%)

40 (100%)

Children aged ≥5 years (n = 28)**

  

Early Treatment Failure (ETF)

0 (0%)

0 (0%)

Late Clinical Failure (LCF)

1 (3.6%)***

0 (0%)

Late Parasitological Failure (LPF)

6 (21.6%)***

0 (0%)

Adequate Clinical and Parasitological Response (ACPR)

21 (75.0%)

21 (100%)

Overall Adequate Clinical and Parasitological Response (ACPR)

61 (77.2/%)

61 (100/%)

  1. *5 lost to follow-up, **4 lost to follow-up.
  2. ***PCR Genotyping showed that they were new infections.